Clean Yield Group Abbott Laboratories Transaction History

Clean Yield Group

$293 Million
Q4 2024

A detailed history of Clean Yield Group transactions in Abbott Laboratories stock. As of the latest transaction made, Clean Yield Group holds 6,385 shares of ABT stock, worth $846,970. This represents 0.25% of its overall portfolio holdings.

Number of Shares

6,385

Previous 6,570 2.82%

Holding current value

$846,970

Previous $749,000 3.6%

% of portfolio

0.25%

Previous 0.25%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 13, 2025	SELL	$111.93 - $119.39 $20,707 - $22,087	-185 Reduced 2.82%	6,385 $722,000
Q3 2024 Oct 07, 2024	BUY	$100.07 - $118.13 $12,108 - $14,293	121 Added 1.88%	6,570 $749,000
Q2 2024 Jul 10, 2024	SELL	$100.73 - $112.44 $20,045 - $22,375	-199 Reduced 2.99%	6,449 $670,000
Q4 2023 Jan 24, 2024	SELL	$90.19 - $110.4 $7,125 - $8,721	-79 Reduced 1.17%	6,648 $731,000
Q3 2023 Oct 12, 2023	BUY	$95.53 - $114.62 $6,304 - $7,564	66 Added 0.99%	6,727 $651,000
Q2 2023 Jul 26, 2023	SELL	$100.78 - $112.29 $10,078 - $11,229	-100 Reduced 1.48%	6,661 $726,000
Q1 2023 Apr 26, 2023	SELL	$96.86 - $114.01 $24,215 - $28,502	-250 Reduced 3.57%	6,761 $684,000
Q4 2022 Jan 31, 2023	SELL	$95.06 - $111.52 $2,471 - $2,899	-26 Reduced 0.37%	7,011 $769,000
Q3 2022 Oct 31, 2022	BUY	$96.76 - $112.03 $2,515 - $2,912	26 Added 0.37%	7,037 $681,000
Q1 2022 Apr 25, 2022	BUY	$114.02 - $139.04 $251,414 - $306,583	2,205 Added 45.88%	7,011 $830,000
Q4 2021 Jan 24, 2022	SELL	$115.53 - $141.46 $72,321 - $88,553	-626 Reduced 11.52%	4,806 $676,000
Q3 2021 Oct 27, 2021	BUY	$116.66 - $129.06 $187,122 - $207,012	1,604 Added 41.9%	5,432 $642,000
Q2 2021 Jul 26, 2021	BUY	$105.79 - $124.53 $154,876 - $182,311	1,464 Added 61.93%	3,828 $444,000
Q4 2020 Jan 26, 2021	SELL	$105.0 - $114.42 $126,000 - $137,304	-1,200 Reduced 33.67%	2,364 $259,000
Q1 2020 Apr 20, 2020	SELL	$62.82 - $91.86 $527,688 - $771,624	-8,400 Reduced 70.21%	3,564 $281,000
Q4 2019 Jan 17, 2020	SELL	$78.51 - $87.4 $9,813 - $10,925	-125 Reduced 1.03%	11,964 $1.04 Million
Q3 2019 Oct 23, 2019	SELL	$81.84 - $88.74 $3,028 - $3,283	-37 Reduced 0.31%	12,089 $1.01 Million
Q2 2019 Jul 22, 2019	BUY	$72.88 - $85.0 $46,643 - $54,400	640 Added 5.57%	12,126 $1.02 Million
Q4 2018 Jan 23, 2019	BUY	$65.56 - $74.27 $49,170 - $55,702	750 Added 6.99%	11,486 $831,000
Q3 2018 Oct 22, 2018	SELL	$60.81 - $73.36 $33,445 - $40,348	-550 Reduced 4.87%	10,736 $788,000
Q2 2018 Jul 24, 2018	SELL	$57.57 - $63.54 $31,663 - $34,947	-550 Reduced 4.65%	11,286 $688,000
Q1 2018 Apr 23, 2018	SELL	$56.27 - $63.62 $506 - $572	-9 Reduced 0.08%	11,836 $709,000
Q3 2017 Oct 11, 2017	BUY	$48.06 - $53.64 $569,270 - $635,365	11,845	11,845 $632,000

Others Institutions Holding ABT

# of Institutions

3,380

Shares Held

1.33B

Call Options Held

10.6M

Put Options Held

8.72M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $232B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clean Yield Group, based on Form 13F filings with the SEC.

News

Stay updated on Clean Yield Group with notifications on news.

Account

Clean Yield Group Abbott Laboratories Transaction History